Providence Alaska Medical Center
- Type
- Teaching hospital
- Where
- ANCHORAGE, AK
- Medicare CCN
- 020001
- Received
- $738,745 in 29 records, 2021 ($8,170 general, $730,575 research)
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2021 | General payment | 10 | $8,170 |
| 2021 | Research payment | 19 | $730,575 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $705,615 | 2021 |
| AstraZeneca UK Limited | 2 | $10,216 | 2021 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $5,428 | 2021 |
| Shockwave Medical, Inc | 1 | $5,000 | 2021 |
| PFIZER INC. | 8 | $4,700 | 2021 |
| AstraZeneca Pharmaceuticals LP | 4 | $3,937 | 2021 |
| Medtronic, Inc. | 2 | $1,150 | 2021 |
| Clovis Oncology, Inc. | 1 | $1,078 | 2021 |
| Siemens Medical Solutions USA, Inc. | 2 | $739 | 2021 |
| Linvatec Corporation | 1 | $666 | 2021 |
| Johnson & Johnson Health Care Systems Inc. | 1 | $157 | 2021 |
| Zimmer Biomet Holdings, Inc. | 2 | $56 | 2021 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 19 | $730,575 |
| Long term medical supply or device loan | 2 | $5,667 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 2 | $1,150 |
| Gift | 1 | $620 |
| Space rental or facility fees (teaching hospital only) | 1 | $400 |
| Debt forgiveness | 2 | $275 |
| Food and Beverage | 2 | $56 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2021-12-31 | Merck Sharp & Dohme LLC | $445,432 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Phase 3, Randomized, Double-blind Trial of Pembrolizumab MK-3475 Plus Enzalutamide Plus ADT Versus Placebo Plus Enzalu | 2021 |
| 2021-12-31 | Merck Sharp & Dohme LLC | $31,016 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A Phase 3, Randomized, Double-blind Trial of Pembrolizumab MK-3475 Plus Enzalutamide Plus ADT Versus Placebo Plus Enzalu | 2021 |
| 2021-12-31 | Shockwave Medical, Inc | $5,000 | Long term medical supply or device loan | In-kind items and services | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Device, Lithoplasty | 2021 | |
| 2021-12-31 | Linvatec Corporation | $666 | Long term medical supply or device loan | In-kind items and services | HALL POWER Device, ORTHOPEDIC SURGERY | 2021 | |
| 2021-12-31 | Siemens Medical Solutions USA, Inc. | $620 | Gift | Cash or cash equivalent | RAPIDPoint 400/405/500 Wash/Waste Cartridge Device, DX - Diagnostics incl. all products and services | 2021 | |
| 2021-12-31 | Siemens Medical Solutions USA, Inc. | $118 | Debt forgiveness | In-kind items and services | 2021 | ||
| 2021-12-31 | AstraZeneca Pharmaceuticals LP | $17 | Research payment | In-kind items and services | LYNPARZA Drug, Oncology | \";A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in P | 2021 |
| 2021-11-24 | Merck Sharp & Dohme LLC | $7,073 | Research payment | Cash or cash equivalent | KEYTRUDA Biological, ONCOLOGY | A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Pembrolizumab MK-3475 Plus Chemotherapy Versus Chemother | 2021 |
| 2021-11-22 | Merck Sharp & Dohme LLC | $222,092 | Research payment | Cash or cash equivalent | KEYTRUDA Biological, ONCOLOGY | A Phase 3, Randomized, Double-blind Trial of Pembrolizumab MK-3475 Plus Enzalutamide Plus ADT Versus Placebo Plus Enzalu | 2021 |
| 2021-10-26 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2021 |
| 2021-09-02 | Medtronic, Inc. | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Minimed 770G System Device, Durable Pump | 2021 | |
| 2021-08-24 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2021 |
| 2021-08-18 | Zimmer Biomet Holdings, Inc. | $32 | Food and Beverage | In-kind items and services | CMF & Thoracic-None Device, CMF & Thoracic | 2021 | |
| 2021-07-26 | PFIZER INC. | $500 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2021 |
| 2021-07-06 | Clovis Oncology, Inc. | $1,078 | Research payment | Cash or cash equivalent | Rubraca Drug, ONCOLOGY | A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Pr | 2021 |
| 2021-06-25 | Medtronic, Inc. | $250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Minimed 770G System Device, Durable Pump | 2021 | |
| 2021-05-28 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2021 |
| 2021-04-16 | AstraZeneca Pharmaceuticals LP | $3,269 | Research payment | In-kind items and services | LYNPARZA Drug, Oncology | This is a non randomized open label study to assess olaparib tablets as a treatment for subjects with different homologo | 2021 |
| 2021-04-02 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2021 |
| 2021-03-18 | AstraZeneca UK Limited | $5,125 | Research payment | Cash or cash equivalent | This study is to assess the efficacy and safety of olaparib monotherapy versus olaparib in combination with an inhibitor | 2021 | |
| 2021-03-18 | AstraZeneca UK Limited | $5,091 | Research payment | Cash or cash equivalent | A Phase 2 Randomised, Multi-Centre Study to Investigate the Efficacy and Tolerability of a Second Maintenance Treatment | 2021 | |
| 2021-03-17 | Zimmer Biomet Holdings, Inc. | $24 | Food and Beverage | In-kind items and services | RibFix Blu Device, CMF & Thoracic | 2021 | |
| 2021-02-12 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2021 |
| 2021-02-12 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2021 |
| 2021-02-12 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2021 |
| 2021-02-09 | AstraZeneca Pharmaceuticals LP | $400 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | BRILINTA Drug, Cardiovascular and Metabolism | 2021 | |
| 2021-01-26 | AstraZeneca Pharmaceuticals LP | $250 | Research payment | Cash or cash equivalent | LYNPARZA Drug, Oncology | \";A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in P | 2021 |
| 2021-01-26 | Johnson & Johnson Health Care Systems Inc. | $157 | Debt forgiveness | In-kind items and services | 2021 | ||
| 2021-01-16 | VERTEX PHARMACEUTICALS INCORPORATED | $5,428 | Research payment | Cash or cash equivalent | A Study to Evaluate the Safety and Efficacy of Long-term Treatment With TEZ/IVA in CF Subjects With an F508del CFTR Muta | 2021 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Anchorage, AK, county Anchorage Municipality, AK, state Alaska; placed by its city name.
| Measure | Place (city or town) Anchorage, AK | County Anchorage Municipality, AK | State Alaska |
|---|---|---|---|
| Population B01003 | 288,976 | 288,976 | 735,706 |
| Population, 2020 census P1 | 291,247 | 291,247 | 733,391 |
| Median age B01002 | 35.2 | 35.2 | 35.8 |
| Under 18 B01001 | 23.5% | 23.5% | 24.1% |
| 65 and over B01001 | 12.9% | 12.9% | 13.8% |
| Households B11001 | 108,597 | 108,597 | 270,533 |
| Foreign born B05002 | 10.9% | 10.9% | 7.7% |
| Median household income B19013 | $103,284 | $103,284 | $92,788 |
| Median family income B19113 | $123,547 | $123,547 | $112,321 |
| Per capita income B19301 | $51,144 | $51,144 | $46,573 |
| Poverty rate B17001 | 8.9% | 8.9% | 10.1% |
| Unemployment rate B23025 | 4.6% | 4.6% | 5.9% |
| Civilian labor force B23025 | 148,419 | 148,419 | 359,445 |
| Mean commute (minutes) B08013 | 18.8 | 18.8 | 19.4 |
| Bachelor's degree or higher B15003 | 38.7% | 38.7% | 31.7% |
| Housing units B25001 | 120,348 | 120,348 | 328,491 |
| Owner-occupied B25003 | 63.9% | 63.9% | 66.8% |
| Renters B25003 | 36.1% | 36.1% | 33.2% |
| Median home value B25077 | $395,900 | $395,900 | $352,900 |
| Median gross rent B25064 | $1,489 | $1,489 | $1,419 |
| White, not Hispanic B03002 | 54.2% | 54.2% | 57.7% |
| Black B03002 | 4.8% | 4.8% | 2.9% |
| Hispanic or Latino B03002 | 9.5% | 9.5% | 7.3% |
| Asian B03002 | 9.8% | 9.8% | 6.4% |
| American Indian and Alaska Native B03002 | 7.0% | 7.0% | 13.2% |
Economy now FRED unemployment 4.3% in Sep 2026 (4.7% a year earlier); per capita personal income $80,510 in 2025, up 30% in five years (+4.6% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Anchorage, AK.
Comments